The Scientist - Home

Under an area-wide “shelter in place” order, scientists at some of the world’s leading universities scramble to continue working while confined to their homes.

A small study of macaques finds they don’t develop a coronavirus infection the second time they are exposed, supporting the idea of using plasma from recovered patients as a treatment for COVID-19.

Coronavirus experts are swamped with reading submissions, which they’re working through as quickly as possible.

Infected children may harbor SARS-CoV-2 while showing less-severe symptoms than adults. Their young immune systems, ACE2 receptor levels, and even exposure to other coronaviruses might play a role in their resilience.

Preliminary modeling studies provide a shortlist of potential coronavirus intermediate host species.

The decline in total occupied forest may not equate to an overall loss in butterfly numbers, but scientists are still concerned that their populations are suffering.

The first volunteer will receive a shot of the synthetic RNA vaccine today.

There is no evidence backing the idea that SARS-CoV-2 originated from US servicemembers visiting Wuhan.

A proof-of-concept study uses a strategy similar to the way tumors evade immune detection. The new limbs survive for more than 200 days.

The 2020 budget includes a 15 percent increase in public funding for research and development next year, but some scientists want more details on where the money will go.

Disease experts have largely focused on how we got to where we are now with coronavirus infections. Improved data collection and sharing can enhance projections of what’s to come.

A preprint indicates that coronavirus transmission from surfaces is possible, but does not provide evidence that this has occurred in the COVID-19 pandemic.